Delivery Order SPE2DB22D1106-SPE2DB25FEVH2
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Glucagon 1 mg Emergency Kits with a ceiling value of $1,069.62 and an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania facility. The contract represents a continuation of AmerisourceBergen's role...
- The Defense Logistics Agency awarded a $4,687.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Glucagon 1 mg emergency kits, with an ultimate completion date of May 13, 2025. This is a non-set-aside contract, competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $5,986.53 to AmerisourceBergen Drug Corp for Glucagon 1 mg Emergency Kits, with an ultimate completion date of August 21, 2025. This firm fixed price contract, issued on August 20, 2025, was awarded through open competition without set-aside designation. The contractor will perform fulfillment from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $5,609.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for Glucagon 1 mg emergency kits on August 27, 2025, with an ultimate completion date of August 28, 2025. This non-set-aside competitive award is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,554.42 to AmerisourceBergen Drug Corp for Glucagon 1 mg Emergency Kits, with an ultimate completion date of June 3, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The contract requires performance at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,301.26 delivery order to AmerisourceBergen Drug Corp for the supply of Glucagon 1 mg Emergency Kits on August 19, 2025, with an ultimate completion date of August 20, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Glucagon 1 mg emergency kits valued at $3,442.00, with an ultimate completion date of November 5, 2025. This non-competitive delivery order utilizes firm fixed price pricing and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with the DLA. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $14,098.87 delivery order to AmerisourceBergen Drug Corp for Glucagon 1 mg Emergency Kits on May 6, 2025, with completion expected by May 7, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $2,955.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Glucagon 1 mg emergency kits, with an ultimate completion date of August 1, 2025. The award was issued on July 31, 2025, with no set-aside designation, indicating competitive selection. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its Corporate Office location. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Glucagon 1 mg Emergency Kits, valued at $9,467.52. The order was competitively awarded without set-aside designation and is scheduled for completion by November 10, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEVH2Delivery Order
The Defense Logistics Agency awarded a $1,598.20 delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for Glucagon 1 mg Emergency Kits, with a completion date of June 27, 2025. This firm fixed price contract, with no set-aside designation, represents a competitively awarded order for emergency medical supplies to support federal healthcare needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the order from its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates consistent capability to deliver medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 6/26/25 |